Skip to Content
Merck
All Photos(1)

Documents

Safety Information

1.20079

Millipore

Eshmuno® Q Resin

Eshmuno® Q

Synonym(s):

Eshmuno® Q

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
47101511

Quality Level

ligand

(Trimethylammoniumethyl)

sterility

sterile (Caustic Stable)

product line

Eshmuno®

form

resin

specific analyte(s)

MAbs

parameter

1000 cm/hr flow rate
1000 cm/hr max. flow rate
8 bar max. pressure

matrix active group

polymer, polyvinyl ether

mean particle size

85 μm

capacity

150 mg binding capacity (BSA/mg of resin)
~150 mg, BSA binding capacity

transition temp

flash point 35 °C (own results)

density

1 g/cm3 at 20 °C

application(s)

recombinant protein
vaccine development

separation technique

anion exchange
mixed mode

storage temp.

2-30°C

Looking for similar products? Visit Product Comparison Guide

General description

Eshmuno® Q resin is a strong anion exchange resin, coupling our renowned tentacle structure with a hydrophilic polyvinyl ether base matrix. Consequently, Eshmuno® Q resin offers outstanding results in typical anion exchange applications, such as removing biomolecules′ impurities in flow-through mode.

Features and Benefits

Eshmuno® Q chromatography resin enables:

  • Purification of acidic and neutral proteins and peptides from different sources, including plasma

Superior productivity for downstream processing of biomolecules
  • High flow rate versus pressure-flow behavior
  • Excellent removal of impurities, such as HCP, leached Protein A, and viruses
  • Robust and safe packing procedures
  • Strong chemical stability

Packaging

  • 1.20079.0100: Eshmuno® Q Resin 100ml
  • 1.20079.0010: Eshmuno® Q Resin 10ml
  • 1.20079.0500: Eshmuno® Q Resin 500ml
  • 1.20079.5000: Eshmuno® Q Resin 5L

Plastic bottle

Analysis Note

Appearance: Milky cream coloured turbid suspension, free from coarse mechanical impurities.
Microscopic evaluation: Spherical particles, no agglomerates, no fines.
Extractable matter (water): ≤ 0.08 %
Ionic capacity: 90 - 190 µeq/ml
Performance test (conalbumin): 9 - 19 mS/cm
Performance test (human serum albumin): 20 - 30 mS/cm
Pressure drop(column: ID=1.6 cm, L=10 cm at 5 ml/min): ≤ 1.0 bar
Protein binding capacity(bovine serum albumin): 120 - 190 mg/ml
Particle size (50-120 µm): ≥ 80 %
Particle size (d50): 75 - 95 µm
Cerium: ≤ 30 µg/g
Endotoxins: ≤ 1.00 EU/ml
TAMC (total aerobic microbial count): ≤ 100 CFU/ml
TYMC (total yeast and mould count): ≤ 100 CFU/ml

Legal Information

Eshmuno is a registered trademark of Merck KGaA, Darmstadt, Germany

Not finding the right product?  

Try our Product Selector Tool.

Pictograms

Flame

Signal Word

Warning

Hazard Statements

Hazard Classifications

Flam. Liq. 3

Storage Class Code

3 - Flammable liquids

WGK

WGK 1

Flash Point(F)

95.0 °F

Flash Point(C)

35 °C


Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

FSL

Group 4: Flammable liquids
Type 2 petroleums
Hazardous rank III
Water insoluble liquid

ISHL Indicated Name

Substances Subject to be Indicated Names

ISHL Notified Names

Substances Subject to be Notified Names

JAN Code

1200795000:
1200790013:
1200790500:
1200790100:
1200790000:
1200790503:
CO1E1200795000:
1200790103:
1200795003:
1200790010:


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Related Content

A relatively templated manufacturing process can be used to produce live vector vaccines. Challenges exist, however, and include yield loss due to sterile filtration, vector aggregation and scaling adherent cultures. Learn all about this core platform technology and how expertise—empowered by collaboration— can overcome manufacturing challenges.

Manufacturing viral vaccines is complex and there is no templated approach. Each process must be tailored to the shape, size, nature, physico-chemical behavior, stability, and host specificity of the virus. Learn all about this core platform technology and how expertise—empowered by collaboration— can overcome manufacturing challenges.

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service